JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
Floor & Decor
FND
$6.32B
| $3.15M | ﹤0.01% |
62,086
-193,378
| -76% | -$9.06M |
|
2927
Dycom Industries
DY
$12.3B
| $3.15M | ﹤0.01% |
66,755
-1,567
| -2% | -$76.3K |
|
2928
Hackett Group
HCKT
$278M
| $3.14M | ﹤0.01% |
194,398
+148,729
| +326% | +$2.36M |
|
2929
ArcelorMittal
MT
$55.2B
| $3.13M | ﹤0.01% |
178,693
-13,774
| -7% | -$223K |
|
2930
Itron
ITRI
$4.49B
| $3.13M | ﹤0.01% |
37,265
-1,746
| -4% | -$137K |
|
2931
Waterstone Financial
WSBF
$378M
| $3.12M | ﹤0.01% |
164,016
+11,118
| +7% | +$205K |
|
|
MDC
2932
DELISTED
M.D.C. Holdings, Inc.
MDC
| $3.12M | ﹤0.01% |
88,260
-192,205
| -69% | -$7.24M |
|
2933
Vanda Pharmaceuticals
VNDA
$314M
| $3.11M | ﹤0.01% |
189,348
-13,977
| -7% | -$211K |
|
2934
Preferred Bank
PFBC
$1.26B
| $3.1M | ﹤0.01% |
51,650
-7,222
| -12% | -$397K |
|
2935
Fidelity Total Bond ETF
FBND
$27.4B
| $3.1M | ﹤0.01% |
59,942
+3,446
| +6% | +$178K |
|
|
ROCC
2936
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $3.1M | ﹤0.01% |
102,142
-16,598
| -14% | -$442K |
|
2937
CALL
Dominion Energy
D
$59.8B
| $3.1M | ﹤0.01% |
37,400
-85,600
| -70% | -$6.99M |
|
2938
Ring Energy
REI
$349M
| $3.09M | ﹤0.01% |
1,170,829
-1,598,800
| -58% | -$3.14M |
|
|
ALX
2939
Alexander's
ALX
$1.39B
| $3.09M | ﹤0.01% |
9,349
-3,711
| -28% | -$1.24M |
|
2940
Vanguard Energy ETF
VDE
$10.4B
| $3.07M | ﹤0.01% |
37,677
-49,512
| -57% | -$3.85M |
|
2941
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.48B
| $3.07M | ﹤0.01% |
62,488
+17,545
| +39% | +$860K |
|
2942
CytomX Therapeutics
CTMX
$760M
| $3.07M | ﹤0.01% |
369,005
+234,743
| +175% | +$1.58M |
|
|
FLXN
2943
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $3.07M | ﹤0.01% |
148,149
+13,976
| +10% | +$236K |
|
|
CMCT
2944
Creative Media & Community Trust
CMCT
$13.7M
| $3.06M | ﹤0.01% |
9
+1
| +13% | +$357K |
|
|
IPHS
2945
DELISTED
Innophos Holdings, Inc.
IPHS
| $3.06M | ﹤0.01% |
95,730
+23,030
| +32% | +$741K |
|
2946
Caleres
CAL
$455M
| $3.05M | ﹤0.01% |
128,469
+110,217
| +604% | +$2.49M |
|
2947
Enel Chile
ENIC
$6.05B
| $3.05M | ﹤0.01% |
642,151
+574,157
| +844% | +$2.48M |
|
2948
Sixth Street Specialty
TSLX
$1.79B
| $3.04M | ﹤0.01% |
141,486
-29,607
| -17% | -$630K |
|
2949
CALL
Tyson Foods
TSN
$19.8B
| $3.03M | ﹤0.01% |
+33,300
| New | +$2.86M |
|
2950
CALL
KLA
KLAC
$274B
| $3.03M | ﹤0.01% |
170,000
-250,000
| -60% | -$4.19M |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.